Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9214 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8836 |
High Similarity |
NPD2532 |
Approved |
0.8836 |
High Similarity |
NPD2533 |
Approved |
0.8836 |
High Similarity |
NPD2534 |
Approved |
0.8618 |
High Similarity |
NPD7819 |
Suspended |
0.8514 |
High Similarity |
NPD6799 |
Approved |
0.8497 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8431 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8421 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8377 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8345 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8322 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8312 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8301 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8299 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8269 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8267 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8264 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8258 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8217 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8199 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8188 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8188 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8163 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8158 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8153 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8105 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8098 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8089 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8089 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8049 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8038 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8037 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8012 |
Intermediate Similarity |
NPD5711 |
Approved |
0.8012 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7974 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7952 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7899 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7879 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7857 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7852 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.777 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7763 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7763 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7746 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7718 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7712 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7708 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7703 |
Intermediate Similarity |
NPD943 |
Approved |
0.7687 |
Intermediate Similarity |
NPD411 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7671 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7658 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7643 |
Intermediate Similarity |
NPD920 |
Approved |
0.7628 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD37 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD919 |
Approved |
0.7607 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7593 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7574 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7547 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7533 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD2654 |
Approved |
0.753 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1608 |
Approved |
0.75 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD9494 |
Approved |
0.747 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7465 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5405 |
Approved |
0.745 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7442 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7442 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7429 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7415 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7384 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7358 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7343 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7317 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7315 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7314 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7292 |
Intermediate Similarity |
NPD17 |
Approved |
0.729 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7225 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7222 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7202 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7174 |
Intermediate Similarity |
NPD74 |
Approved |
0.7174 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7171 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7159 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7143
|
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |